Doctor, academic, classics student, arts patron and philanthropist Paul Eliadis believes in not only saving lives but culturally enriching them
Read MoreMultiple trials now demonstrate the potential for success and the safety of an attempt at treatment-free remission (TFR) in patients with sustained deep molecular response to tyrosine kinase inhibitors (TKIs) [1,2,3].
Read MoreSIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer
Read More1